Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Gary Steinberg, MD, PhD
Stanford Hospital and Clinics, School of Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
65 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- University of Alabama at Birmingham (surgical/assessment)
Birmingham, Alabama, United States
- Xenoscience, Inc. (assessment)
Phoenix, Arizona, United States
- the Research Center of Southern California (assessment)
Carlsbad, California, United States
- Rancho Los Amigos National Rehab Center
Downey, California, United States
- Neuro Pain Medical Center
Fresno, California, United States
- Neuro-Pain Medical Center (assessment)
Fresno, California, United States
- University of California Irvine
Irvine, California, United States
- Ronald Reagan Ucla Medical Center (assessment/surgical)
Los Angeles, California, United States
- Ucla Medical Center
Los Angeles, California, United States
- University of California Irvine (assessment)
Orange, California, United States
- Westview Clinical Research (assessment)
Placentia, California, United States
- Providence Saint John'S Health Center (assessment)
Santa Monica, California, United States
- Providence St. John'S Health Center (surgical)
Santa Monica, California, United States
- Providence St. Johns Health Center
Santa Monica, California, United States
- Stanford Health Care (surgical/assessment)
Stanford, California, United States
- New England Institute for Clinical Research (assessment)
Stamford, Connecticut, United States
- Medstar National Rehabilitation Hospital (assessment)
Washington D.C., District of Columbia, United States
- University of Miami Jackson Memorial Hospital
Miami, Florida, United States
- University of Miami Miller School of Medicine (assessment/surgical)
Miami, Florida, United States
- Neuromedical Research Institute (assessment)
Panama City, Florida, United States
- Medsol Clinical Research Center (assessment)
Port Charlotte, Florida, United States
- Neurostudies, Inc. (assessment)
Port Charlotte, Florida, United States
- University of South Florida (assessment)
Tampa, Florida, United States
- Emory University Hospital (surgical)
Atlanta, Georgia, United States
- Grady Memorial Hospital (assessment)
Atlanta, Georgia, United States
- Center for Advanced Research and Education (assessment)
Gainesville, Georgia, United States
- Northwestern Memorial Hospital (surgical)
Chicago, Illinois, United States
- Rehabilitation Institute of Chicago
Chicago, Illinois, United States
- University of Chicago Medical Center (assessment)
Chicago, Illinois, United States
- University of Chicago Medical Center (surgical)
Chicago, Illinois, United States
- Consultants in Neurology, Ltd. (assessment)
Northbrook, Illinois, United States
- Osf Saint Francis Healthcare System (assessment)
Peoria, Illinois, United States
- Indiana Medical Research, Elkhart Clinic (assessment)
Elkhart, Indiana, United States
- University of Kansas Medical Center (surgical)
Kansas City, Kansas, United States
- Kansas Institute of Research (assessment)
Overland Park, Kansas, United States
- University of Kentucky Hospital (surgical)
Lexington, Kentucky, United States
- University of Louisville Clinical Trials Unit (assessment)
Louisville, Kentucky, United States
- Neuromedical Clinic of Central Louisiana (assessment)
Alexandria, Louisiana, United States
- Beth Israel Deaconess Medical Center (surgical)
Boston, Massachusetts, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Mar 2016
- Primary completion
- 5 Dec 2018
- Completion
- 5 Dec 2018
- Last update posted
- 8 Oct 2020
- Registered enrollment
- 163
- Registry id
- NCT02448641
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.